US stocks added to records on Tuesday, with the blistering rally since last week slowing slightly as traders prepared to take ...
AbbVie said a recently acquired drug candidate for schizophrenia missed the key goal in mid-stage studies, pushing its stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback